Literature DB >> 20863627

Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes.

John J Mariani1, Daniel Brooks, Margaret Haney, Frances R Levin.   

Abstract

The quantification method for collecting self-reported marijuana use data is not standardized as it is for alcohol or cigarettes, which presents a methodologic challenge for marijuana use disorder treatment studies. Serum and urine markers of marijuana use have a long half-life, limiting their utility as a clinical trial outcome measure. Structured calendar-based interview procedures can accurately measure the frequency of self-reported marijuana use, but are unable to reliably address issues such as quantity of use or potency. This study compared the quantity and assigned-dollar value among users of blunts, joints, and pipes enrolled in two clinical trials testing pharmacotherapies for marijuana dependence. The timeline follow-back method was modified to incorporate using a surrogate substance to represent marijuana to enable participants to estimate the amount and value used. Blunt users were mostly black and Hispanic, while users of joints and pipes were primarily white. Participants reported that they placed 50% more marijuana in blunts than in joints and placed more than twice the amount of marijuana in blunts than in pipes. These findings demonstrate the feasibility of using a surrogate weight estimation procedure to augment calendar-based methods of measuring self-reported marijuana use. Individual variability in use practices limits the utility of this method to estimating within-subject comparisons, rather than between subject comparisons.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20863627      PMCID: PMC3025094          DOI: 10.1016/j.drugalcdep.2010.08.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

1.  The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties.

Authors:  W Fals-Stewart; T J O'Farrell; T T Freitas; S K McFarlin; P Rutigliano
Journal:  J Consult Clin Psychol       Date:  2000-02

2.  Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing.

Authors:  Betty J Buchan; Michael L Dennis; Frank M Tims; Guy S Diamond
Journal:  Addiction       Date:  2002-12       Impact factor: 6.526

3.  Combining psychometric and biometric measures of substance use.

Authors:  Richard Lennox; Michael L Dennis; Christy K Scott; Rod Funk
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

4.  The construct and predictive validity of different approaches to combining urine and self-reported drug use measures among older adolescents after substance abuse treatment.

Authors:  Richard Lennox; Michael L Dennis; Melissa Ives; Michelle K White
Journal:  Am J Addict       Date:  2006

Review 5.  The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs.

Authors:  Bruce D Johnson; Andrew Golub
Journal:  Drug Alcohol Depend       Date:  2006-09-15       Impact factor: 4.492

6.  Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram.

Authors:  Stephen J Sifaneck; Geoffrey L Ream; Bruce D Johnson; Eloise Dunlap
Journal:  Drug Alcohol Depend       Date:  2006-10-20       Impact factor: 4.492

7.  Assessment of cocaine use with quantitative urinalysis and estimation of new uses.

Authors:  K L Preston; K Silverman; C R Schuster; E J Cone
Journal:  Addiction       Date:  1997-06       Impact factor: 6.526

8.  Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

Authors:  M A Huestis; J M Mitchell; E J Cone
Journal:  J Anal Toxicol       Date:  1996-10       Impact factor: 3.367

9.  Cannabinoid concentrations in hair from documented cannabis users.

Authors:  Marilyn A Huestis; Richard A Gustafson; Eric T Moolchan; Allan Barnes; James A Bourland; Stacy A Sweeney; Eugene F Hayes; Patrick M Carpenter; Michael L Smith
Journal:  Forensic Sci Int       Date:  2006-09-11       Impact factor: 2.395

10.  Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.

Authors:  M A Huestis; E J Cone
Journal:  Ther Drug Monit       Date:  1998-10       Impact factor: 3.681

View more
  61 in total

Review 1.  The co-occurring use and misuse of cannabis and tobacco: a review.

Authors:  Arpana Agrawal; Alan J Budney; Michael T Lynskey
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

2.  Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Erin A McClure; Nathaniel L Baker; Susan C Sonne; Udi E Ghitza; Rachel L Tomko; LaTrice Montgomery; Shanna Babalonis; Garth E Terry; Kevin M Gray
Journal:  Drug Alcohol Depend       Date:  2018-08-25       Impact factor: 4.492

3.  Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.

Authors:  Brian J Sherman; Aimee L McRae-Clark; Nathaniel L Baker; Susan C Sonne; Therese K Killeen; Kasie Cloud; Kevin M Gray
Journal:  Am J Addict       Date:  2017-02-02

4.  Further validation of a marijuana purchase task.

Authors:  Elizabeth R Aston; Jane Metrik; James MacKillop
Journal:  Drug Alcohol Depend       Date:  2015-05-11       Impact factor: 4.492

Review 5.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

6.  A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Authors:  Kevin M Gray; Susan C Sonne; Erin A McClure; Udi E Ghitza; Abigail G Matthews; Aimee L McRae-Clark; Kathleen M Carroll; Jennifer S Potter; Katharina Wiest; Larissa J Mooney; Albert Hasson; Sharon L Walsh; Michelle R Lofwall; Shanna Babalonis; Robert W Lindblad; Steven Sparenborg; Aimee Wahle; Jacqueline S King; Nathaniel L Baker; Rachel L Tomko; Louise F Haynes; Ryan G Vandrey; Frances R Levin
Journal:  Drug Alcohol Depend       Date:  2017-06-10       Impact factor: 4.492

7.  Characterizing Blunt Use Among Twitter Users: Racial/Ethnic Differences in Use Patterns and Characteristics.

Authors:  LaTrice Montgomery; Kamonta Heidelburg; Cendrine Robinson
Journal:  Subst Use Misuse       Date:  2017-09-14       Impact factor: 2.164

8.  Psychosocial and cessation-related differences between tobacco-marijuana co-users and single product users in a college student population.

Authors:  Matthew N Masters; Regine Haardörfer; Michael Windle; Carla Berg
Journal:  Addict Behav       Date:  2017-09-18       Impact factor: 3.913

9.  Marijuana use and intoxication among daily users: an intensive longitudinal study.

Authors:  John R Hughes; James R Fingar; Alan J Budney; Shelly Naud; John E Helzer; Peter W Callas
Journal:  Addict Behav       Date:  2014-06-04       Impact factor: 3.913

10.  Open-label pilot study of quetiapine treatment for cannabis dependence.

Authors:  John J Mariani; Martina Pavlicova; Agnieszka K Mamczur; Adam Bisaga; Edward V Nunes; Frances R Levin
Journal:  Am J Drug Alcohol Abuse       Date:  2014-07       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.